Monopar Therapeutics Inc.’s stock has experienced significant fluctuations over the past year, closing at $34.505 on June 9, 2025, with a market capitalization of approximately $226.94 million.

Monopar Therapeutics Inc.’s stock has experienced significant fluctuations over the past year, closing at $34.505 on June 9, 2025, with a market capitalization of approximately $226.94 million.

Monopar Therapeutics Inc. is advancing in cancer drug development, with a focus on improving clinical outcomes for patients through innovative research and drug combinations.